Auto saved by Logseq

assets/Rethinking_Chagas_Report_21JUN2021-1_1704450708173_0.edn

@@ -285,5 +285,34 @@
                                    :height 1584}),
                           :page 4},
                :content {:text "Explore opportunities to reduce the entry barrier for new tests, including rapid tests"},
+               :properties {:color "yellow"}}
+              {:id #uuid "6597ec3b-74c2-4eaa-a2f4-61965df57526",
+               :page 5,
+               :position {:bounding {:x1 143.93691635131836,
+                                     :y1 597.3485412597656,
+                                     :x2 1072.0851860046387,
+                                     :y2 682.0172424316406,
+                                     :width 1224,
+                                     :height 1584},
+                          :rects ({:x1 229.75837326049805,
+                                   :y1 597.3485412597656,
+                                   :x2 1072.0851860046387,
+                                   :y2 624.3694152832031,
+                                   :width 1224,
+                                   :height 1584}
+                                  {:x1 143.93691635131836,
+                                   :y1 626.1723937988281,
+                                   :x2 1072.0726127624512,
+                                   :y2 653.1933898925781,
+                                   :width 1224,
+                                   :height 1584}
+                                  {:x1 143.93691635131836,
+                                   :y1 654.9962463378906,
+                                   :x2 527.8879203796387,
+                                   :y2 682.0172424316406,
+                                   :width 1224,
+                                   :height 1584}),
+                          :page 5},
+               :content {:text "Some unpublished research indicates that commercial tests may be missing more than half of infections acquired in southern Mexico. In addition, there is a pressing need to explore new technologies(e.g. CRISPR) that could facilitate diagnosis"},
                :properties {:color "yellow"}}],
- :extra {:page 5}}
+ :extra {:page 6}}

pages/hls__Rethinking_Chagas_Report_21JUN2021-1_1704450708173_0.md

@@ -60,4 +60,9 @@ file-path:: ../assets/Rethinking_Chagas_Report_21JUN2021-1_1704450708173_0.pdf
   ls-type:: annotation
   hl-page:: 4
   hl-color:: yellow
-  id:: 6597ebbe-e6fb-4b11-8901-8a4dc8950543
+  id:: 6597ebbe-e6fb-4b11-8901-8a4dc8950543
+- Some unpublished research indicates that commercial tests may be missing more than half of infections acquired in southern Mexico. In addition, there is a pressing need to explore new technologies(e.g. CRISPR) that could facilitate diagnosis
+  ls-type:: annotation
+  hl-page:: 5
+  hl-color:: yellow
+  id:: 6597ec3b-74c2-4eaa-a2f4-61965df57526